🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is intended to estimate the absolute bioavailability of Glasdegi...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2017-09-07
Trial ID
NCT03270878
Treatments Being Tested
The study aims to understand, using radiolabelled PF-04449913, how this com...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-05
Trial ID
NCT02110342
Treatments Being Tested
Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2017-07-07
Trial ID
NCT03226418
Glasdegib is being studied in combination with azacitidine for the treatmen...
Status
Completed
Location
UCLA Department of Medicine
Start Date
2018-04-20
Trial ID
NCT03416179
Treatments Being Tested
This is a study to evaluate PF-04449913 (an inhibitor of the Hedgehog pathw...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-06-27
Trial ID
NCT01546038
A lead-in cohort of \~20 patients with primary or secondary myelofibrosis p...
Status
Terminated
Location
Mayo Clinic Building - Phoenix
Start Date
2014-10-06
Trial ID
NCT02226172
Treatments Being Tested
This is a Phase 1, open-label, parallel group, single dose study to investi...
Status
Completed
Location
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy
Start Date
2018-11-05
Trial ID
NCT03627754
Treatments Being Tested
This is an open-label, multi-center, Phase 1 study of PF-04449913 in Japane...
Status
Completed
Location
Japanese Red Cross Nagoya First Hospital
Start Date
2014-03-25
Trial ID
NCT02038777